KALA BIO, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
KALA BIO, INC. (KALA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 65.05 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-15
- KALA BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 65.05M shares, a 16.10% increase year-over-year.
- KALA BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 64.55M shares, a 15.89% increase year-over-year.
- KALA BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 61.66M shares, a 51.26% increase year-over-year.
- KALA BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 56.96M shares, a 63.17% increase year-over-year.
- KALA BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 52.38M shares, a 53.11% increase from fiscal 2019.
- KALA BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 34.21M shares, a 27.87% increase from fiscal 2018.
- KALA BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 26.75M shares, a 135.20% increase from fiscal 2017.
- KALA BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 11.38M shares, a 862.82% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2021-09-30 | 65.05M shares 10-Q · filed 2021-11-15 | 64.80M shares derived: average of 2 quarters · filed 2021-11-15 | 63.77M shares 10-Q · filed 2021-11-15 | 62.05M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2021-06-30 | 64.55M shares 10-Q · filed 2021-08-05 | 63.11M shares 10-Q · filed 2021-08-05 | 61.06M shares derived: average of 3 quarters · filed 2021-08-05 | 59.80M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2021-03-31 | 61.66M shares 10-Q · filed 2021-05-05 | 59.31M shares derived: average of 2 quarters · filed 2021-05-05 | 58.21M shares derived: average of 3 quarters · filed 2021-11-15 | 57.59M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2020-12-31 | 56.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 56.49M shares derived: average of 2 quarters · filed 2021-11-15 | 56.23M shares derived: average of 3 quarters · filed 2021-11-15 | 52.38M shares 10-K · filed 2021-02-25 | |
| 2020-09-30 | 56.03M shares 10-Q · filed 2021-11-15 | 55.87M shares derived: average of 2 quarters · filed 2021-11-15 | 50.85M shares 10-Q · filed 2021-11-15 | 46.85M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | 55.70M shares 10-Q · filed 2021-08-05 | 48.23M shares 10-Q · filed 2021-08-05 | 43.79M shares derived: average of 3 quarters · filed 2021-08-05 | 41.39M shares derived: average of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | 40.76M shares 10-Q · filed 2021-05-05 | 37.83M shares derived: average of 2 quarters · filed 2021-05-05 | 36.61M shares derived: average of 3 quarters · filed 2021-05-05 | 35.93M shares derived: average of 4 quarters · filed 2021-05-05 | |
| 2019-12-31 | 34.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 34.54M shares derived: average of 2 quarters · filed 2021-02-25 | 34.32M shares derived: average of 3 quarters · filed 2021-02-25 | 34.21M shares 10-K · filed 2021-02-25 | |
| 2019-09-30 | 34.17M shares 10-Q · filed 2020-11-05 | 34.03M shares derived: average of 2 quarters · filed 2020-11-05 | 33.98M shares 10-Q · filed 2020-11-05 | 33.81M shares derived: average of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | 33.88M shares 10-Q · filed 2020-08-06 | 33.88M shares 10-Q · filed 2020-08-06 | 33.69M shares derived: average of 3 quarters · filed 2020-08-06 | 31.42M shares derived: average of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | 33.88M shares 10-Q · filed 2020-05-07 | 33.59M shares derived: average of 2 quarters · filed 2020-05-07 | 30.59M shares derived: average of 3 quarters · filed 2020-05-07 | 29.09M shares derived: average of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | 33.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | 28.95M shares derived: average of 2 quarters · filed 2020-02-12 | 27.49M shares derived: average of 3 quarters · filed 2020-02-12 | 26.75M shares 10-K · filed 2020-02-12 | |
| 2018-09-30 | 24.60M shares 10-Q · filed 2019-11-07 | 24.58M shares derived: average of 2 quarters · filed 2019-11-07 | 24.57M shares 10-Q · filed 2019-11-07 | 24.66M shares derived: average of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | 24.57M shares 10-Q · filed 2019-08-06 | 24.55M shares 10-Q · filed 2019-08-06 | 24.68M shares derived: average of 3 quarters · filed 2019-08-06 | 23.02M shares derived: average of 4 quarters · filed 2019-08-06 | |
| 2018-03-31 | 24.54M shares 10-Q · filed 2019-05-09 | 24.73M shares derived: average of 2 quarters · filed 2019-05-09 | 22.50M shares derived: average of 3 quarters · filed 2019-05-09 | 17.17M shares derived: average of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | 24.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 21.48M shares derived: average of 2 quarters · filed 2019-03-12 | 14.71M shares derived: average of 3 quarters · filed 2019-03-12 | 11.38M shares 10-K · filed 2019-03-12 | 6.90M shares 10-K · filed 2018-04-02 |
| 2017-09-30 | 18.03M shares 10-Q · filed 2018-11-08 | 9.61M shares derived: average of 2 quarters · filed 2018-11-08 | 6.86M shares 10-Q · filed 2018-11-08 | 5.39M shares derived: average of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | 1.18M shares 10-Q · filed 2018-08-09 | 1.18M shares 10-Q · filed 2018-08-09 | 1.18M shares derived: average of 3 quarters · filed 2018-08-09 | 1.18M shares derived: average of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | 1.18M shares 10-Q · filed 2018-05-10 | 1.18M shares derived: average of 2 quarters · filed 2018-05-10 | 1.18M shares derived: average of 3 quarters · filed 2018-05-10 | 1.18M shares derived: average of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | 1.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 1.18M shares derived: average of 2 quarters · filed 2018-04-02 | 1.18M shares derived: average of 3 quarters · filed 2018-04-02 | 1.18M shares 10-K · filed 2018-04-02 | |
| 2016-09-30 | 1.18M shares 10-Q · filed 2017-11-07 | 1.18M shares derived: average of 2 quarters · filed 2017-11-07 | 1.18M shares 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | 1.18M shares 10-Q · filed 2017-08-31 | 1.18M shares 10-Q · filed 2017-08-31 | |||
| 2015-12-31 | 1.12M shares 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |